Financial results - DALY MEDIVET S.R.L.

Financial Summary - Daly Medivet S.r.l.
Unique identification code: 30008650
Registration number: J14/91/2012
Nace: 7500
Sales - Ron
110.484
Net Profit - Ron
9.702
Employee
4
The most important financial indicators for the company Daly Medivet S.r.l. - Unique Identification Number 30008650: sales in 2023 was 110.484 euro, registering a net profit of 9.702 euro and having an average number of 4 employees. Firma isi desfasoara activitatea in domeniul Activitati veterinare having the NACE code 7500.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Daly Medivet S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 15.085 23.542 23.071 38.506 47.836 58.225 58.081 73.918 100.449 110.484
Total Income - EUR 15.206 23.672 23.071 40.450 48.249 58.225 58.082 73.918 100.452 110.496
Total Expenses - EUR 13.594 20.202 21.270 34.927 43.599 47.057 55.572 69.101 89.305 99.744
Gross Profit/Loss - EUR 1.613 3.470 1.801 5.523 4.651 11.168 2.510 4.817 11.147 10.752
Net Profit/Loss - EUR 1.157 2.760 1.532 5.138 4.172 10.586 1.974 4.293 10.196 9.702
Employees 1 1 2 4 3 3 3 3 4 4
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 10.3%, from 100.449 euro in the year 2022, to 110.484 euro in 2023. The Net Profit decreased by -463 euro, from 10.196 euro in 2022, to 9.702 in the last year.

Check the financial reports for the company - Daly Medivet S.r.l.

Rating financiar

Financial Rating -
Daly Medivet S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Daly Medivet S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Daly Medivet S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Daly Medivet S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Daly Medivet S.r.l. - CUI 30008650

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 3.070 2.674 2.229 1.781 19.299 14.637 10.152 12.888 11.854 8.448
Current Assets 4.144 5.048 7.370 13.721 12.475 32.966 28.834 35.237 41.717 64.449
Inventories 3.955 1.415 2.440 6.915 9.767 11.261 18.306 20.040 19.682 25.836
Receivables 0 0 0 996 1.318 6.915 6.784 7.279 9.798 14.613
Cash 189 3.633 4.931 5.811 1.390 14.790 3.743 7.918 12.237 24.000
Shareholders Funds 4.287 7.083 8.543 13.536 17.460 27.707 29.156 32.802 43.100 52.671
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 2.927 639 1.057 1.965 14.314 19.895 9.830 15.323 10.471 20.226
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "7500 - 7500"
CAEN Financial Year 7500
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 64.449 euro in 2023 which includes Inventories of 25.836 euro, Receivables of 14.613 euro and cash availability of 24.000 euro.
The company's Equity was valued at 52.671 euro, while total Liabilities amounted to 20.226 euro. Equity increased by 9.702 euro, from 43.100 euro in 2022, to 52.671 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Daly Medivet S.r.l.

Comments - Daly Medivet S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.